Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996-2016

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diet and physical activity in Greenland: genetic interactions and associations with obesity and diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Introduction Lifetime risk and lifetime lost to diabetes are measures of current diabetes burden in a population. We aimed at quantifying these measures in the Danish population. Research design and methods We modeled incidence and mortality of type 1 diabetes (T1D) and type 2 diabetes (T2D) and non-diabetes mortality based on complete follow-up of the entire population of Denmark in 1996-2016. A multistate model with these transition rates was used to assess the lifetime risk of diabetes, as well as the difference in expected lifetime between persons with type 1 and T2D and persons without. Results In 2016, the lifetime risk of T1D was 1.1% and that for T2D 24%, the latter a 50% increase from 1996. For 50-year-old persons, the lifetime lost was 6.6 years for T1D and 4.8 years for T2D. These figures have been declining over the study period. At 2016, the total foreseeable lives lost in Denmark among patients with T1D were 182 000 years, and those among patients with T2D were 766 000 years, corresponding to 6.6 and 3.0 years per person, respectively. Conclusion At the individual level, improvements in the disease burden for both T1D and T2D have occurred. At the population level, the increasing number of patients with T2D has contributed to a large increase in the total loss of lifetime.

Original languageEnglish
Article numbere001065
JournalBMJ Open Diabetes Research and Care
Issue number1
Publication statusPublished - 2 Mar 2021

    Research areas

  • Cost of Illness, Denmark/epidemiology, Diabetes Mellitus, Type 1/epidemiology, Diabetes Mellitus, Type 2/epidemiology, Humans, Incidence, Middle Aged

ID: 67559722